Undergraduate education

Oberlin College, BS, 2005

Years in MSTP



Molecular and cellular pharmacology, 2012


Randy Tibbetts, PhD

Thesis title

Roles of TDP-43 and Ubiquilin 1 in Neurodegenerative Disease


Pediatrics, University of Wisconsin-Madison, 2013-2016

Current position

Clinical assistant professor, Department of Pediatrics, University of Illinois-Peoria, College of Medicine

PhD publications

Zhan L, Hanson KA, Kim SH, Tare A, Tibbetts RS. Identification of Genetic Modifiers of TDP-43 Neurotoxicity in Drosophila. PLoS One. 2013;8(2):e57214. PMID: 23468938; PMCID: PMC3584124.

Kim SH, Zhan L, Hanson KA, Tibbetts RS. High-content RNAi screening identifies the Type 1 inositol triphosphate receptor as a modifier of TDP-43 localization and neurotoxicity. Hum Mol Genet. Nov 15;21(22):4845-56. PMID: 22872699; PMCID: PMC 3529575.

Hanson KA, Kim SH, Tibbetts RS. RNA-binding proteins in neurodegenerative disease: TDP-43 and beyond. Wiley Interdiscip Rev RNA. 2012 Mar;3(2):265-85. doi: 10.1002/wrna.111. PMID: 22028183; PMCID: PMC3766724.

Hanson KA, Kim SH, Wassarman DA, Tibbetts RS. Ubiquilin modifies TDP-43 toxicity in a Drosophila model of amyotrophic lateral sclerosis (ALS). J Biol Chem. 2010 Apr 9;285(15):11068-72. PMID: 20154090; PMCID: PMC2856981.

Kim SH, Shi Y, Hanson KA, Williams LM, Sakasai R, Bowler MJ, Tibbetts RS. Potentiation of amyotrophic lateral sclerosis (ALS)-associated TDP-43 aggregation by the proteasome-targeting factor, ubiquilin 1. J Biol Chem. 2009 Mar 20;284(12):8083-92. PMID: 19112176; PMCID: PMC2658102.